Skip to main content
SpringerLink
Log in

PET Scanning in Staging and Evaluation of Response to Treatment in Lung Cancer

  • Chapter
Advances in Radiation Oncology in Lung Cancer

Part of the book series: Medical Radiology Radiation Oncology ((Med Radiol Radiat Oncol))

  • 887 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abou-Zied M, Zubeldia J, Nabi H (2000) 30. Follow-up of patients with single pulmonary nodules and negative 18f-fluorodeoxyglucose positron emission tomography scans. Clin Positron Imaging 3:184

    Article  PubMed  Google Scholar 

  • Ackerly T, Andrews J, Ball D, Binns D, Clark R, D'Costa I, et al. (2002) Display of positron emission tomography with Cadplan. Australas Phys Eng Sci Med 25:67–77

    PubMed  Google Scholar 

  • Akhurst T, Downey RJ, Ginsberg MS, Gonen M, Bains M, Korst R, et al. (2002) An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73:259–264

    Article  PubMed  Google Scholar 

  • Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H et al. (2003) Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526–533

    PubMed  Google Scholar 

  • Ball D, Smith J, Wirth A, Mac Manus M (2002) Failure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy. Int J Radiat Oncol Biol Phys 54:1007–1013

    Article  PubMed  Google Scholar 

  • Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. (2003) Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44:1200–1209

    PubMed  Google Scholar 

  • Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, et al. (2003) Imaging proliferation in lung tumors with PET: 18F-FT versus 18F-FDG. J Nucl Med 44:1426–1431

    PubMed  Google Scholar 

  • Bury T, Dowlati A, Paulus P, Hustinx R, Radermecker M, Rigo P (1996) Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography. Eur J Nucl Med 23:20420–20426

    Article  Google Scholar 

  • Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P (1998) Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 25:1244–1247

    Article  PubMed  Google Scholar 

  • Bury T, Corhay JL, Duysinx B, Daenen F, Ghaye B, Barthelemy N, et al. (1999) Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 14:1376–1380

    Article  PubMed  Google Scholar 

  • Choi NC, Fischman AJ, Niemierko A, Ryu JS, Lynch T, Wain J, et al. (2002) Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54:1024–1035

    Article  PubMed  Google Scholar 

  • Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, et al. (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 57:853–863

    Article  PubMed  Google Scholar 

  • Croft DR, Trapp J, Kernstine K, Kirchner P, Mullan B, Galvin J, et al. (2002) FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence. Lung Cancer 36:297–301

    Article  PubMed  Google Scholar 

  • DeGrado TR, Reiman RE, Price DT, Wang S, Coleman RE (2002) Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med 43:92–96

    PubMed  Google Scholar 

  • Dunagan D, Chin R, Jr., McCain T, Case L, Harkness B, Oaks T, et al. (2001) Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. Chest 119:333–339

    Article  PubMed  Google Scholar 

  • Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL (1999) Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology 213:530–536

    PubMed  Google Scholar 

  • Erdi YE, Macapinlac H, Rosenzweig KE, Humm JL, Larson SM, Erdi AK, et al. (2000) Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 27:861–866

    Article  PubMed  Google Scholar 

  • Erdi YE, Rosenzweig K, Erdi AK, Macapinlac HA, Hu YC, Braban LE, et al. (2002) Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62:51–60

    Article  PubMed  Google Scholar 

  • Eschmann SM, Friedel G, Paulsen F, Budach W, Harer-Mouline C, Dohmen BM, et al. (2002) FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy. Eur J Nucl Med Mol Imaging 29:804–808

    PubMed  Google Scholar 

  • Farrell MA, McAdams HP, Herndon JE, Patz EF, Jr. (2000) Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. Radiology 215:886–890

    PubMed  Google Scholar 

  • Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D (2003) Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 5:26–31

    Article  PubMed  Google Scholar 

  • Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, et al. (2000) Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 216:117–121

    PubMed  Google Scholar 

  • Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914–924

    Article  PubMed  Google Scholar 

  • Green S, Weiss GR (1992) Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10:239–253

    Article  PubMed  Google Scholar 

  • Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK (2002) Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29:1393–1398

    PubMed  Google Scholar 

  • Hara T, Inagaki K, Kosaka N, Morita T (2000) Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J Nucl Med 41:1507–1513

    PubMed  Google Scholar 

  • Hicks RJ, MacManus MP (2003) 18F-FDG PET in candidates for radiation therapy: is it important and how do we validate its impact? J Nucl Med 44:30–32

    PubMed  Google Scholar 

  • Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, et al. (2001) The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med 42:1605–1613

    PubMed  Google Scholar 

  • Higashi K, Ueda Y, Yagishita M, Arisaka Y, Sakurai A, Oguchi M, et al. (2000) FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 41:85–92

    PubMed  Google Scholar 

  • Higashi K, Ueda Y, Sakuma T, Seki H, Oguchi M, Taniguchi M, et al. (2001) Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med 42:1489–1496

    PubMed  Google Scholar 

  • Hoekstra CJ, Hoekstra OS, Stroobants SG, Vansteenkiste J, Nuyts J, Smit EF, et al. (2002) Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET. J Nucl Med 43:1304–1309

    PubMed  Google Scholar 

  • Hutton BF, Braun M, Thurfjell L, Lau DY (2002) Image registration: an essential tool for nuclear medicine. Eur J Nucl Med Mol Imaging 29:559–577

    Article  PubMed  Google Scholar 

  • Kalff V, Hicks RJ, MacManus MP, Binns DS, McKenzie AF, Ware RE, et al. (2001) Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 19:111–118

    PubMed  Google Scholar 

  • Kiffer JD, Berlangieri SU, Scott AM, Quong G, Feigen M, Schumer W, et al. (1998) The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19:167–177

    Article  PubMed  Google Scholar 

  • Lever AM, Henderson D, Ellis DA, Corris PA, Gilmartin JJ (1984) Radiation fibrosis mimicking local recurrence in small cell carcinoma of the bronchus. Br J Radiol 57:178–180

    PubMed  Google Scholar 

  • MacManus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E et al. (2001a) F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 92:886–895

    Article  PubMed  Google Scholar 

  • MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, et al. (2001b) High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50:287–293

    Article  PubMed  Google Scholar 

  • MacManus MP, Hicks RJ, Ball DL, Ciavarella F, Binns D, Hogg A, et al. (2001c) Imaging with F-18 FDG PET is superior to T1-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy. Australas Radiol 45:483–490

    Article  PubMed  Google Scholar 

  • MacManus MP, Hicks R, Fisher R, Rischin D, Michael M, Wirth A, et al. (2003a) FDG-PET-detected extracranial metastasis in patients with non-small cell lung cancer undergoing staging for surgery or radical radiotherapy-survival correlates with metastatic disease burden. Acta Oncol 42:48–54

    Article  PubMed  Google Scholar 

  • MacManus MP, Hicks RJ, Matthews JP, McKenzie A, Rischin D, Salminen EK, et al. (2003b) Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 21:1285–1292

    Article  PubMed  Google Scholar 

  • Mah K, Caldwell CB, Ung YC, Danjoux CE, Balogh JM, Ganguli SN, et al. (2002) The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 52:339–350

    Article  PubMed  Google Scholar 

  • Mankoff DA, Shields AF, Link JM, Graham MM, Muzi M, Peterson LM, et al. (1999) Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies. J Nucl Med 40:614–624

    PubMed  Google Scholar 

  • Marom EM, McAdams HP, Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, et al. (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212:803–809

    PubMed  Google Scholar 

  • Mountain CF, Lukeman JM, Hammar SP, Chamberlain DW, Coulson WF, Page DL, et al. (1987) Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 35:147–156

    PubMed  Google Scholar 

  • Nettelbladt OS, Sundin AE, Valind SO, Gustafsson GR, Lamberg K, Langstrom B, et al. (1998) Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. J Nucl Med 39:640–647

    PubMed  Google Scholar 

  • Pandit N, Gonen M, Krug L, Larson SM (2003) Prognostic value of [18F]FDG-PET imaging in small cell lung cancer. Eur J Nucl Med Mol Imaging 30:78–84

    PubMed  Google Scholar 

  • Pieterman RM, Que TH, Elsinga PH, Pruim J, van Putten JW, Willemsen AT, et al. (2002) Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. J Nucl Med 43:167–172

    PubMed  Google Scholar 

  • Pitman AG, Hicks RJ, Kalff V, Binns DS, Ware RE, McKenzie AF, et al. (2001) Positron emission tomography in pulmonary masses where tissue diagnosis is unhelpful or not possible. Med J Aust 175:303–307

    PubMed  Google Scholar 

  • Pitman AG, Hicks RJ, Binns DS, Ware RE, Kalff V, McKenzie AF, et al. (2002) Performance of sodium iodide based (18)F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses. Br J Radiol 75:114–121

    PubMed  Google Scholar 

  • Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P (2001) PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma. Eur J Cardiothorac Surg 20:468–474

    Article  PubMed  Google Scholar 

  • Sasaki M, Kuwabara Y, Yoshida T, Nakagawa M, Koga H, Hayashi K, et al. (2001) Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung. Ann Nucl Med 15:425–431

    PubMed  Google Scholar 

  • Schmucking M, Baum RP, Griesinger F, Presselt N, Bonnet R, Przetak C, et al. (2003) Molecular whole-body cancer staging using positron emission tomography: consequences for therapeutic management and metabolic radiation treatment planning. Recent Results Cancer Res 162:195–202

    PubMed  Google Scholar 

  • Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. (1998) Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4:1334–1336

    Article  PubMed  Google Scholar 

  • Stroobants S, Verschakelen J, Vansteenkiste J (2003) Value of FDG-PET in the management of non-small cell lung cancer. Eur J Radiol 45:49–59

    Article  PubMed  Google Scholar 

  • Timms B (2000) Positron-emission tomography (PET) superior to computed tomography for staging and detecting metastasis. Eur J Cancer 36:1888

    Google Scholar 

  • Toloza EM, Harpole L, McCrory DC (2003) Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123(1 suppl):137S–146S

    Article  PubMed  Google Scholar 

  • Townsend DW, Beyer T (2002) A combined PET/CT scanner: the path to true image fusion. Br J Radiol 75 Spec No:24–30

    PubMed  Google Scholar 

  • Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al. (1995) Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 60:1573–1581

    Article  PubMed  Google Scholar 

  • Van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, et al. (2002) Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359:1388–1393

    Article  PubMed  Google Scholar 

  • Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, et al. (1997) Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 112:1480–1486

    PubMed  Google Scholar 

  • Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verbeken EK (1998) Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven Lung Cancer Group. Ann Oncol 9:1193–1198

    Article  PubMed  Google Scholar 

  • Verboom P, Van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, et al. (2003) Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study. Eur J Nud Med Mol Imaging 30:1444–1449

    Article  Google Scholar 

  • Vesselle HJ, Miraldi FD (1998) FDG PET of the retroperitoneum: normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics 18:805–823

    PubMed  Google Scholar 

  • Vesselle H, Schmidt RA, Pugsley JM, Li M, Kohlmyer SG, Vallires E, et al. (2000) Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837–3844

    PubMed  Google Scholar 

  • Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB (1994) Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 191:371–377

    PubMed  Google Scholar 

  • Weber WA, Petersen V, Schmidt B, Tyndale-Hines L, Link T, Peschel C, et al. (2003) Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 21:2651–2657

    Article  PubMed  Google Scholar 

  • Werner-Wasik M, Xiao Y, Pequignot E, Curran WJ, Hauck W (2001) Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study. Int J Radiat Oncol Biol Phys 51:56–61

    Article  Google Scholar 

  • Yasukawa T, Yoshikawa K, Aoyagi H, Yamamoto N, Tamura K, Suzuki K, et al. (2000) Usefulness of PET with 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med 41:283–290

    PubMed  Google Scholar 

  • Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A (2001) 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42:1795–1799

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, Victoria, 3002, Australia

    Michael P. MacManus MD (Associate Professor)

  2. Centre for Molecular Imaging, Peter MacCallum Cancer Institute, 12 Cathedral Place, East Melbourne, Victoria, 3002, Australia

    Rodney J. Hicks MB, BS (Hons), MD, FRACP (Associate Professor of Medicine and Radiology)

Authors
  1. Michael P. MacManus MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodney J. Hicks MB, BS (Hons), MD, FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 226, 81657, München, Germany

    Branislav Jeremić MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

MacManus, M.P., Hicks, R.J. (2005). PET Scanning in Staging and Evaluation of Response to Treatment in Lung Cancer. In: Jeremić, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology Radiation Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26632-1_36

Download citation

  • DOI: https://doi.org/10.1007/3-540-26632-1_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00522-3

  • Online ISBN: 978-3-540-26632-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation